Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 2, Issue 1, 2007, Pages 112-120

  Torres, Vicente E ^a   King, Bernard F ^a   Chapman, Arlene B ^b   Brummer, Marijn E ^b   Bae, Kyongtae T ^g   Glockner, James F ^a   Arya, Kraisthith ^b   Risk, Dana ^b   Felmlee, Joel P ^a   Grantham, Jared J ^c   Guay Woodford, Lisa M ^d   Bennett, William M ^e   Klahr, Saulo ^g   Meyers, Catherine M ^f   Zhang, Xiaoling ^g   Thompson, Paul A ^g   Miller, J Philip ^g  

^a Mayo Clinic College of Medicine   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e Northwest Renal Clinic   (United States)

^f NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^g WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY; KIDNEY CIRCULATION; KIDNEY POLYCYSTIC DISEASE; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; REGRESSION ANALYSIS;

ADOLESCENT; ADULT; BLOOD PRESSURE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RENAL CIRCULATION;

EID: 34047273663     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00910306     Document Type: Article

References (38)

1. Grantham JJ, Chapman AB, Torres VE: Volume progression in autosomal dominant polycystic kidney disease: The major factor determining clinical outcomes. Clin J Am Soc Nephrol 1: 148-157, 2006
2. Schacht F: Hypertension and Vascular Studies in Congenital Polycystic Kidney [master's thesis], St. Paul, University of Minnesota, 1930
3. Zeier M, Fehrenbach P, Geberth S, Mohring K, Waldherr R, Ritz E: Renal histology in polycystic kidney disease with incipient and advanced renal failure. Kidney Int 42: 1259-1265, 1992
4. Gabow PA, Chapman AB, Johnson AM, Tangel DJ, Duley IT, Kaehny WD, Manco-Johnson M, Schrier RW: Renal structure and hypertension in autosomal dominant polycystic kidney disease. Kidney Int 38: 1177-1180, 1990
5. Griffin MD, Torres VE, Grande JP, Kumar R: Vascular expression of polycystin. J Am Soc Nephrol 8: 616-626, 1997
6. Torres VE, Cai Y, Chen X, Wu GQ, Geng L, Cleghorn KA, Johnson CM, Somlo S: Vascular expression of polycystin 2. J Am Soc Nephrol 12: 1-9, 2001
7. Qian Q, Li M, Cai Y, Ward CJ, Somlo S, Harris PC, Torres VE: Analysis of the polycystins in aortic vascular smooth muscle cells. J Am Soc Nephrol 14: 2280-2287, 2003
8. Ibraghimov-Beskrovnaya O, Dackowski WR, Foggensteiner L, Coleman N, Thiru S, Petry LR, Burn TC, Connors TD, Van Raay T, Bradley J, Qian F, Onuchic LF, Watnick TJ, Piontek K, Hakim RM, Landes GM, Germino GG, Sandford R, Klinger KW: Polycystin: In vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein Proc Natl Acad Sci U S A 94: 6397-6402, 1997
9. Qian Q, Hunter LW, Li M, Marin-Padilla M, Prakash YS, Harris PC, Somlo S, Torres VE, Sieck GC: Pkd2 haploin-sufficiency alters intracellular calcium in vascular smooth muscle cells. Hum Mol Genet 12: 1875-1880, 2003
10. Kip SN, Hunter LW, Ren Q, Harris PC, Somlo S, Torres VE, Sieck GC, Qian Q: [Ca2+]i reduction increases cellular proliferation and apoptosis in vascular smooth muscle cells: Relevance to the ADPKD phenotype. Circ Res 96: 873-880, 2005
11. Wang D, Iversen J, Wilcox CS, Strandgaard S: Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease. Kidney Int 64: 1381-1388, 2003
12. Kocaman O, Oflaz H, Yekeler E, Dursun M, Erdogan D, Demirel S, Alisir S, Turgut F, Mercanoglu F, Ecder T: Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 43: 854-860, 2004
13. Chapman A, Guay-Woodford L, Grantham JJ, Torres V, Bae K, Baumgarten D, Kenney P, King B, Glockner J, Wetzel L, Brummer M, O'Neill C, Robbin M, Bennett W, Klahr S, Hirschman G, Kimmel P, Thompson P, Miller J: Renal structure in early autosomal dominant polycystic kidney disease (ADPKD); the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) Cohort. Kidney Int 64: 1035-1045, 2003
14. King BF, Torres VE, Brummer ME, Chapman AB, Bae KT, Glockner JF, Arya K, Felmlee JP, Grantham JJ, Guay-Woodford LM, Bennett WM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP: Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease. Kidney Int 64: 2214-2221, 2003
15. Rule AD, Torres VE, Chapman AB, J GJ, Guay-Woodford LM, Bae KT, Klahr S, Bennett WM, Meyers CM, Thompson PA, Miller JP; CRISP: Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: The Consortium of Radiologic Imaging studies of Polycystic Kidney Disease Cohort. J Am Soc Nephrol 17: 854-862, 2006
16. Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF Jr, Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, Klahr S, Bennett WM, Hirschman GN, Meyers CM, Zhang X, Zhu F, Miller JP: Volume progression in polycystic kidney disease. N Engl J Med 354: 2122-2130, 2006
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
18. Maroni BJ, Steinman TI, Mitch WE: A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 27: 58-65, 1985
19. Bae KT, Commean PK, Lee J: Volumetric measurement of renal cysts and parenchyma using MRI: Phantoms and patients with polycystic kidney disease. J Comput Assist Tomogr 24: 614-619, 2000
20. De Leeuw P, Kho T, Falke H, Birkenhager W, Wester A: Haemodynamic and endocrinological profile of essential hypertension. Acta Med Scand Suppl 622: 1-86, 1978
21. Brummer ME, Dambreville S, King BF, Chapman AB, Glockner J, Torres VE, Wallin A, Bae KT, Miller JP, Ladson J, Agress L, Frakes D, Yoganathan A: Renal Blood Flow Measurement by Breathhold Phase-Velocity MRI: A Validation Study. Presented at the annual meeting of the ISMRM, Miami, FL, May 7-13, 2005
22. Grantham JJ: Lillian Jean Kaplan International Prize for advancement in the understanding of polycystic kidney disease. Understanding polycystic kidney disease: A systems biology approach. Kidney Int 64: 1157-1162, 2003
23. Rossetti S, Burton S, Strmecki L, Pond GR, San Millan JL, Zerres K, Barratt TM, Ozen S, Torres VE, Bergstralh EJ, Winearls CG, Harris PC: The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. J Am Soc Nephrol 13: 1230-1237, 2002
24. Hateboer N, van Dijk MA, Bogdanova N, Coto E, Saggar-Malik AK, San Millan JL, Torra R, Breuning M, Ravine D: Comparison of phenotypes of polycystic kidney disease types 1 and 2. Lancet 353: 103-107, 1999
25. Johnson A, Gabow P: Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease. J Am Soc Nephrol 8: 1560-1567, 1997
26. Chapman AB, Johnson A, Gabow PA, Schrier RW: The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med 323: 1091-1096, 1990
27. Torres VE, Wilson DM, Burnett JCJ, Johnson CM, Offord KP: Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease. Mayo Clin Proc 66: 1010-1017, 1991
28. Watson M, Macnicol A, Allan P, Wright A: Effects of angiotensin-converting enzyme inhibition in adult polycystic kidney disease. Kidney Int 41: 206-210, 1992
29. Keith DS, Torres VE, Johnson CM, Holley KE: Effect of sodium chloride, enalapril, and losartan on the development of polycystic kidney disease in Han:SPRD rats. Am J Kidney Dis 24: 491-498, 1994
30. Ogborn M, Sareen S, Pinette G: Cilazapril delays progression of hypertension and uremia in rat polycystic kidney disease. Am J Kidney Dis 26: 942-946, 1995
31. Kennefick T, Al-Nimri M, Oyama T, Thompson M, Kelly F, Chapman J, Anderson S: Hypertension and renal injury in experimental polycystic kidney disease. Kidney Int 56: 2181-2190, 1999
32. Dixon R, Brunskill NJ: Albumin stimulates p44/p42 extra-cellular-signal-regulated mitogen-activated protein kinase in opossum kidney proximal tubular cells. Clin Sci (Lond) 98: 295-301, 2000
33. Erkan E, De Leon M, Devarajan P: Albumin overload induces apoptosis in LLC-PK(1) cells. Am J Physiol Renal Physiol 280: F1107-F1114, 2001
34. Lee EM, Pollock CA, Drumm K, Barden JA, Poronnik P: Effects of pathophysiological concentrations of albumin on NHE3 activity and cell proliferation in primary cultures of human proximal tubule cells. Am J Physiol Renal Physiol 285: F748-F757, 2003
35. Erkan E, Devarajan P, Schwartz GJ: Apoptotic response to albumin overload: Proximal vs. distal/collecting tubule cells. Am J Nephrol 25: 121-131, 2005
36. Wong H, Vivian L, Weiler G, Filler G: Patients with autosomal dominant polycystic kidney disease hyperfiltrate early in their disease. Am J Kidney Dis 43: 624-628, 2004
37. Bello E, Caramelo C, Martell N, Alcazar JM, Gonzalez J, Lopez MD, Ruilope LM, Gonzalez FR, Rovira AM, Gazapo R, Soldevilla MJ, Casado S: Impairment of renal vasodilation with 1-arginine is related to more severe disease in untreated hypertensive patients. Hypertension 38: 907-912, 2001
38. Nakagawa T, Kang DH, Feig D, Sanchez-Lozada LG, Srinivas TR, Sautin Y, Ejaz AA, Segal M, Johnson RJ: Unearthing uric acid: An ancient factor with recently found significance in renal and cardiovascular disease. Kidney Int 69: 1722-1725, 2006